Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics Munich, |
RCV000995903 | SCV001150295 | likely pathogenic | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | 2018-07-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000995903 | SCV005088891 | pathogenic | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | 2021-03-30 | criteria provided, single submitter | clinical testing | This variant (reported as c.105dupT; p.V36fs*52) was previously reported in two siblings diagnosed with TMEM70 deficiency in a family in homozygous state [PMID: 30950220]. In addition, other truncating variants lying downstream of the identified variant, have been previously reported as ‘pathogenic’ in the ClinVar database context of nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2. |
OMIM | RCV000995903 | SCV001428444 | pathogenic | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | 2020-08-13 | no assertion criteria provided | literature only |